Billede af showet Labcat.ai Read Alzheimer's Disease Paper

Labcat.ai Read Alzheimer's Disease Paper

Podcast af meng

engelsk

Sundhed & personlig udvikling

Begrænset tilbud

1 måned kun 9 kr.

Derefter 99 kr. / månedOpsig når som helst.

  • 20 lydbogstimer pr. måned
  • Podcasts kun på Podimo
  • Gratis podcasts
Kom i gang

Læs mere Labcat.ai Read Alzheimer's Disease Paper

• 🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor • 🏥 Clinical insights and how institutions are responding • 💡 Therapeutic innovations and emerging treatment targets • 🎯 Practical takeaways for physicians, neurologists, and medical researchers Get journal's impact factors at : https://www.journalmetrics.org Find clinical trials easily : https://www.clinicaltrialsfind.com Find NIH grants trend: https://www.gotgrant.com

Alle episoder

238 episoder

episode June 29, 2026 - Alzheimer Research Update cover

June 29, 2026 - Alzheimer Research Update

June 29, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Neuroprotective Effects of Tenoxicam and Phenethyl Isothiocyanate in an Aβ₁₋₄₂-Induced Rat Model of Alzheimer's Disease: Modulation of NF-κB/NLRP3 Signaling and Redox Homeostasis. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

I går - 2 min
episode June 28, 2026 - Alzheimer Research Update cover

June 28, 2026 - Alzheimer Research Update

June 28, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: RNA G-quadruplexes function as a tunable switch of FUS phase separation. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

28. juni 2026 - 2 min
episode June 27, 2026 - Alzheimer Research Update cover

June 27, 2026 - Alzheimer Research Update

June 27, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Extracellular vesicle-mediated bidirectional communication between the brain and peripheral organs in Alzheimer's disease: evidence, mechanisms, and translational perspectives. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

27. juni 2026 - 2 min
episode June 26, 2026 - Alzheimer Research Update cover

June 26, 2026 - Alzheimer Research Update

June 26, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: From Plastics to Pathology: The Neurodegenerative Impact of Bisphenol-A on Alzheimer's Disease. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

26. juni 2026 - 1 min
episode June 25, 2026 - Alzheimer Research Update cover

June 25, 2026 - Alzheimer Research Update

June 25, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: a systematic review and network meta-analysis of phase III trials. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

25. juni 2026 - 2 min
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
En fantastisk app med et enormt stort udvalg af spændende podcasts. Podimo formår virkelig at lave godt indhold, der takler de lidt mere svære emner. At der så også er lydbøger oveni til en billig pris, gør at det er blevet min favorit app.
Rigtig god tjeneste med gode eksklusive podcasts og derudover et kæmpe udvalg af podcasts og lydbøger. Kan varmt anbefales, om ikke andet så udelukkende pga Dårligdommerne, Klovn podcast, Hakkedrengene og Han duo 😁 👍
Podimo er blevet uundværlig! Til lange bilture, hverdagen, rengøringen og i det hele taget, når man trænger til lidt adspredelse.

Vælg dit abonnement

Mest populære

Begrænset tilbud

Premium

20 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

1 måned kun 9 kr.
Derefter 99 kr. / måned

Kom i gang

Premium Plus

100 timers lydbøger

  • Podcasts kun på Podimo

  • Ingen reklamer i podcasts fra Podimo

  • Opsig når som helst

Prøv gratis i 30 dage
Derefter 129 kr. / måned

Prøv gratis

Kun på Podimo

Populære lydbøger

Ofte stillede spørgsmål

Flere spørgsmål og svar
Kom i gang

1 måned kun 9 kr. Derefter 99 kr. / måned. Opsig når som helst.